Clinical Trials Directory

Trials / Sponsors / Longboard Pharmaceuticals

Longboard Pharmaceuticals

Industry · 6 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Enrolling By InvitationA Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
Developmental and Epileptic Encephalopathy
Phase 32025-02-12
RecruitingA Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
Developmental and Epileptic Encephalopathy
Phase 32024-11-11
RecruitingA Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Dravet Syndrome
Phase 32024-09-25
CompletedOpen-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome
Phase 22022-11-08
CompletedStudy to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox Gastaut Syndrome
Phase 1 / Phase 22022-03-03
AvailableIntermediate-Size Expanded Access Protocol (EAP) for LP352
Dravet Syndrome, Lennox Gastaut Syndrome, Developmental and Epileptic Encephalopathies
——